GlaxoSmithKline CEO optimistic COVID-19 vaccine widely available in 2021

The chief executive of GlaxoSmithKline, the world's largest maker of vaccines, said she was optimistic the industry will be able to make an immunisation against COVID-19 widely available next year.GSK is contributing adjuvants, efficacy boosters that play a vital role in many vaccines, in several development alliances for potential future vaccines against the novel coronavirus that has claimed more than a million lives globally.Walmsley stressed the industry's unprecedented speed of developing a